New York, NY, United States of America

William G Bornmann



Average Co-Inventor Count = 4.3

ph-index = 8

Forward Citations = 121(Granted Patents)


Location History:

  • New York, NY (US) (1995 - 2005)
  • Missouri City, TX (US) (2012 - 2019)

Company Filing History:


Years Active: 1995-2019

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: **Innovative Contributions of William G. Bornmann in Cancer Research**

Introduction

William G. Bornmann is a prominent inventor based in New York, NY, who has made significant contributions to the field of cancer research. With an impressive portfolio of 15 patents, he has developed innovative compounds and methods that aim to tackle various medical challenges, particularly in treating cancer and inflammatory diseases.

Latest Patents

Among his recent inventions, William G. Bornmann has patented compounds that serve as enolase inhibitors. These compounds, defined by a specific formula, are capable of preferentially inhibiting one isoenzyme of enolase over others, which is crucial for targeted therapeutic applications. Additionally, he has developed compounds that exhibit anti-cancer and anti-inflammatory properties, providing novel methods for treating diseases such as cancer and other hyperproliferative conditions.

Career Highlights

Throughout his career, Bornmann has worked with prestigious institutions, including the Sloan Kettering Institute for Cancer Research and the University of Texas System. His tenure at these organizations has been characterized by a commitment to developing innovative solutions that address critical health issues.

Collaborations

William G. Bornmann has collaborated with esteemed colleagues in the field, including Samuel J. Danishefsky and Wang Shen. These partnerships have enabled him to leverage diverse expertise, further enhancing the impact of his research and inventions.

Conclusion

In summary, William G. Bornmann’s innovative spirit and dedication to cancer research have resulted in significant advancements in treatment methodologies. His patents reflect a commitment to improving health outcomes through scientific discovery and collaboration. As the medical community continues to explore the potential of his inventions, Bornmann remains a key figure to watch in the realm of biomedical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…